Inactive Instrument
BioLargo, Inc. Stock Other OTC
Stocks
BLGO
US09065A1007
Commodity Chemicals
OTC Markets Traded| Market Cap | 33.43M 29.06M 27.05M 24.83M 46.89M 3.19B 47.62M 319M 125M 1.59B 126M 123M 5.33B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 33.43M 29.06M 27.05M 24.83M 46.89M 3.19B 47.62M 319M 125M 1.59B 126M 123M 5.33B | EV / Sales 2026 * |
6.34x | EV / Sales 2027 * | - |
| Free-Float |
85.93% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioLargo, Inc.
| 1 day | +3.41% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dennis Calvert
CEO | Chief Executive Officer | 62 | 2002-05-31 |
Charles Dargan
DFI | Director of Finance/CFO | 70 | 2008-01-31 |
| Chief Operating Officer | 56 | 2002-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenneth Code
BRD | Director/Board Member | 78 | 2007-03-31 |
Dennis Calvert
CHM | Chairman | 62 | 2002-05-31 |
| Director/Board Member | 56 | 2002-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.41% | +0.22% | - | - | 33.43M | |
| -0.59% | -3.29% | +8.68% | +26.45% | 125B | |
| -0.52% | -6.24% | -9.24% | -42.12% | 39.62B | |
| -2.68% | +1.03% | +19.58% | -23.78% | 34.53B | |
| +10.00% | -10.14% | +289.50% | +127.86% | 39.17B | |
| -2.47% | -0.38% | +49.87% | +64.48% | 25.08B | |
| +2.71% | +2.92% | +7.16% | -37.20% | 20.04B | |
| +1.03% | +4.34% | +75.45% | +235.08% | 18.72B | |
| -1.20% | +6.64% | +35.23% | -2.75% | 17.52B | |
| -1.18% | +4.83% | +8.22% | +7.46% | 17.42B | |
| Average | +0.85% | -0.44% | +53.83% | +39.50% | 37.45B | |
| Weighted average by Cap. | +0.52% | -2.11% | +48.36% | +33.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.28M 4.59M 4.27M 3.92M 7.4M 504M 7.52M 50.32M 19.75M 251M 19.81M 19.38M 841M | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Commodity Chemicals
